De novo design of a stapled peptide targeting SARS-CoV-2 spike protein receptor-binding domain
Description
Although effective vaccines have been developed against SARS-CoV-2, many regions in the world still have low rates of vaccination and new variants with mutations in the viral spike protein have reduced the effectiveness of most available vaccines and
